Medication Profile—Long Term Care

Date of admission: 4/30
Patient Name: Philips Doe
Race: African American
Address: 5342 Maybe St.
Height: 5'11”
Age: 59
Weight: 220
Gender: M
Allergies: NKA

Diagnosis
Chronic renal failure, hypertension, diabetes mellitus, peripheral vascular disease, anemia, angina

Admission orders
 
Date
Name and Strength
Route
Sig
1.
4/30
Dilantin® 100 mg
PO
i q8h
2.
4/30
Nicotine 14 mg/24 h patch
PO
i qd
3.
4/30
Isordil® 10 mg
PO
i tid
4.
4/30
Diabeta® 5 mg
PO
ii qam
5.
4/30
Diabeta® 5 mg
PO
i qhs
6.
4/30
ReglanTM 10 mg
PO
i qid
7.
4/30
Colace® 100 mg
PO
i bid
8.
4/30
Tylenol® 325 mg
PO
ii q4h prn
9.
4/30
Bisacodyl supp 10 mg
PR
i qd prn
10.
4/30
Milk of magnesia 80 mg/mL
PO
30 cc qd prn
11.
4/30
Nitrostat® 0.4 mg SL
SL
i q5min prn chest pain
12.
4/30
Ativan® 0.5 mg
PO
i-ii tab prn anxiety
13.
4/30
Ambien® 5 mg
PO
i hs prn insomnia

Notes and patient information
Date     Comments
6/28      Signs of gingival hyperplasia observed at am visit

Use the patient profile above to answer the following questions.

1.
Monitoring parameters for Dilantin® include
I. Blood pressure
II. Plasma phenytoin levels
III. Serum albumin levels
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


2.
Following a loading dose of phenytoin a level should be drawn within?
A.
2–6 h
B.
6–12 h
C.
12–24 h
D.
24–48 h
E.
48–96 h


3.
Routes of administration for phenytoin include
I. PO
II. IV
III. IM
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


4.
Which of the drugs listed for Mr. Doe may be responsible for his gingival hyperplasia
I. Dilantin®
II. Nicotine
III. Diabeta®
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I and III


5.
Toxic levels of phenytoin are generally in the range of
A.
1 to 10 µg/mL
B.
10 to 20 µg/mL
C.
15 to 35 µg/mL
D.
30 to 50 µg/mL
E.
> 100 µg/mL


6.
Which of the drugs listed for Mr. Doe could give him chest pain and cause him to have to use Nitrostat to relieve it?
A.
Diabeta®
B.
Dilantin®
C.
Nicotine
D.
Isordil®
E.
ReglanTM


7.
Recommended dosing times for Isordil® include
I. 7 AM, 12 PM, 5 PM
II. 7 AM, 3 PM, 11 PM
III. 12 PM, 8 PM, 4 AM
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


8.
Mr. Doe has refused his last two meals because he says that he lost his appetite. Which of the drugs listed for Mr. Doe should be withheld at least until he starts eating his meals regularly?
A.
Nicotine
B.
Dilantin®
C.
Diabeta®
D.
ReglanTM
E.
Colace®


9.
Which of the drugs listed for Mr. Doe can accelerate gastric emptying without stimulating gastric, biliary, or pancreatic secretions?
I. ReglanTM
II. Diabeta®
III. Dilantin®
A.
I only
B.
II only
C.
III only
D.
I and II
E.
I, II, and III


10.
Which of the drugs listed for Mr. Doe is FDA approved for the symptomatic treatment of diabetic gastric stasis?
A.
Dilantin®
B.
Diabeta®
C.
ReglanTM
D.
Ativan®
E.
Colace®


STOP This is the end of the test. When you have completed all the questions and reviewed your answers, press the button below to grade the test.